EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Honokiol Inhibits Arsenic Trioxide–Induced Cardiomyopathy by Modulating Ferroptosis via SIRT3 Signaling Pathway

Qing-Qing Wei iD, An-Liang Huang, Ning-Yi Liu, Yi-Ran Zhang, Fan Yang iD

Cardiology Research and Practice · 2026-01 · 2026 (1)

DOI: 10.1155/crp/8878178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiology Research and Practice, online erschienen am 02.08.2026. Verfasst von Qing-Qing Wei und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, North Sichuan Medical College, Nanchong, Sichuan, China, scu.edu.cn. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chengdu Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis has recently been identified as a critical mechanism underlying arsenic trioxide (ATO)–induced cardiotoxicity. This study aimed to determine whether Honokiol (HKL) protects against ATO‐induced cardiac injury by inhibiting ferroptosis and to investigate the role of the SIRT3 signaling pathway in this process. Using 129S1/SvImJ wild‐type (WT) and SIRT3‐knockout (SIRT3 −/− ) mice, we demonstrated that HKL attenuates ATO‐induced myocardial injury and hypertrophy in a SIRT3‐dependent manner. Mechanistically, HKL reduced oxidative stress through the SIRT3/SOD2 pathway, as evidenced by decreased mitochondrial ROS production and SOD2 acetylation, along with preserved mitochondrial ATP generation capacity. Furthermore, HKL inhibited ferroptosis, indicated by reduced iron content, MDA levels, and 4‐HNE expression, along with restored GPX4 and GSH levels. Notably, HKL restored autophagic flux impaired by ATO, and this effect was associated with its antiferroptotic and cardioprotective actions. Pharmacological or genetic inhibition of SIRT3 or autophagic flux abolished the protective effects of HKL. Autophagic flux is closely associated with the protective effect of Honokiol on ATO‐induced ferroptosis. These findings reveal that HKL protects against ATO‐induced cardiomyopathy by restoring autophagic flux and inhibiting ferroptosis via the SIRT3 signaling pathway.

Schlagwörter

Stichwörter der Autor:innen

HonokiolSIRT3arsenic trioxideautophagic fluxcardiotoxicityferroptosis

Autor:innen und Institutionen

  • School of Basic Medicine, North Sichuan Medical College, Nanchong, Sichuan, China, scu.edu.cn.
  • Department of Pathology, Chengdu Fifth People's Hospital The Second Clinical Medical College, Cancer Prevention and Treatment Institute of Chengdu, Affiliated Fifth People's Hospital of Chengdu University of Traditional…
  • School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China, scu.edu.cn.

ORCID-Profile: Qing-Qing Wei, Fan Yang

Förderung

  • Chengdu Science and Technology Bureau

Zitieren

APA

Wei, Q. Q., Huang, A. L., Liu, N. Y., Zhang, Y. R., & Yang, F. (2026). Honokiol Inhibits Arsenic Trioxide–Induced Cardiomyopathy by Modulating Ferroptosis via SIRT3 Signaling Pathway. Cardiology Research and Practice, 2026(1). https://doi.org/10.1155/crp/8878178

Vancouver

Wei QQ, Huang AL, Liu NY, Zhang YR, Yang F. Honokiol Inhibits Arsenic Trioxide–Induced Cardiomyopathy by Modulating Ferroptosis via SIRT3 Signaling Pathway. Cardiology Research and Practice. 2026;2026(1). doi:10.1155/crp/8878178

BibTeX
@article{Wei2026,
  author = {Wei, Qing-Qing and Huang, An-Liang and Liu, Ning-Yi and Zhang, Yi-Ran and Yang, Fan},
  title = {Honokiol Inhibits Arsenic Trioxide–Induced Cardiomyopathy by Modulating Ferroptosis via SIRT3 Signaling Pathway},
  journal = {Cardiology Research and Practice},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crp/8878178}
}
Kostenlos starten →